Next Article in Journal
Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge
Next Article in Special Issue
Vaccines and Vaccine Adjuvants for Infectious Diseases and Autoimmune Diseases
Previous Article in Journal
Vaccine Champions Training Program: Empowering Community Leaders to Advocate for COVID-19 Vaccines
 
 
Article

Article Versions Notes

Vaccines 2022, 10(11), 1894; https://doi.org/10.3390/vaccines10111894
Action Date Notes Link
article xml file uploaded 10 November 2022 07:46 CET Original file -
article xml uploaded. 10 November 2022 07:46 CET Update https://www.mdpi.com/2076-393X/10/11/1894/xml
article pdf uploaded. 10 November 2022 07:46 CET Version of Record https://www.mdpi.com/2076-393X/10/11/1894/pdf
article supplementary file uploaded. 10 November 2022 07:46 CET - https://www.mdpi.com/2076-393X/10/11/1894#supplementary
article html file updated 10 November 2022 07:47 CET Original file -
article html file updated 28 February 2023 22:18 CET Update -
article html file updated 2 March 2023 22:14 CET Update https://www.mdpi.com/2076-393X/10/11/1894/html
Back to TopTop